BioNTech, Crelux, 4SC deal

4SC's 4SC Discovery GmbH subsidiary, Crelux and BioNTech's Ribological GmbH subsidiary partnered to identify and optimize compounds to be used with RNA molecules from Ribological in cancer immunothera...